4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000072
Chief Financial Officer sold 10,000 shares at $38.46 ($384,600)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Girao Tiago Chief Financial Officer | 2026-06-26 | Option exercise | +10,000 | $15.90 | $159,000 | 257,596 | D |
| Girao Tiago Chief Financial Officer | 2026-06-26 | Sale | −10,000 | $38.46 | $384,600 | 247,596 | D |
| Derivatives | |||||||
| Girao Tiago Chief Financial Officer | 2026-06-26 | Option exercise · Stock Option (right to buy) | −10,000 | 283,505 | D | ||
| Open-market sales · 10,000 sh · avg $38.46 · $384,600 | |||||||
Loading xslF345X06/wk-form4_1782517438.xml…